药物筛检市场－全球产业规模、份额、趋势、机会和预测，按产品和服务、样本类型、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球药物筛检市场规模为55.6亿美元，预计2030年将以5.3%的复合年增长率成长至75.8亿美元。全球药物筛检市场涵盖用于检测生物样本中非法物质、管制药物及其代谢物的检测解决方案的开发、生产和分销。该市场成长的主要驱动因素是全球药物滥用问题日益严重，以及包括工作场所和交通运输在内的各个领域对药物检测的严格监管要求。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球药物筛选市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品及服务分类（药物筛检产品、分析仪器、快速检测设备、口腔液检测设备、耗材、药物筛检服务）
  • 依样本类型（尿液样本、呼气样本、口腔液样本、毛髮样本、其他样本）
  • 按最终使用者划分（药物检测实验室、工作场所、刑事司法和执法机构、医院、戒毒治疗中心、个人使用者、疼痛管理中心、学校和学院）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美药物筛检市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲药物筛检市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区药物筛选市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲药物筛检市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲药物筛检市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球药物筛选市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Quest Diagnostics Inc.
• Heska Corporation
• Thermo Fisher Scientific, Inc.
• Alfa Scientific Designs, Inc.
• OraSure Technologies, Inc.
• F. Hoffmann-La Roche Ltd
• MPD Inc.
• Shimadzu Corporation
• Lifeloc Technologies, Inc.
• Dragerwerk AG & Co. KGaA
• Premier Biotech, Inc.
• Omega Laboratories, Inc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Drug Screening Market, valued at USD 5.56 Billion in 2024, is projected to experience a CAGR of 5.3% to reach USD 7.58 Billion by 2030. The global drug screening market is defined by the development, production, and distribution of testing solutions designed to detect illicit substances, controlled medications, and their metabolites in biological samples. This market's growth is primarily driven by the escalating global incidence of substance abuse and stringent regulatory mandates for drug testing across diverse sectors, including workplaces and transportation.

Key Market Drivers

The global drug screening market is significantly influenced by the escalating rates of substance abuse worldwide. As illicit drug use continues to rise, there is a corresponding surge in the demand for effective screening solutions across various sectors, including healthcare, workplaces, and criminal justice. This heightened prevalence of drug use necessitates robust detection methods to safeguard public health and maintain societal order. According to the UNODC World Drug Report 2024, the number of people who use drugs globally rose to 292 million in 2022, marking a 20 percent increase over the preceding decade. This trend directly fuels the need for expanded drug testing programs, driving both the volume of tests performed and the innovation required to detect a broader spectrum of substances.

Key Market Challenges

The continuous emergence of novel synthetic drugs and designer substances presents a substantial impediment to the growth of the global drug screening market. These rapidly evolving compounds frequently bypass existing detection methodologies, requiring constant and significant analytical innovation from screening providers. This dynamic landscape compels market participants to dedicate substantial resources to ongoing research and development efforts, increasing operational costs and extending timelines for test kit validation and deployment.

Key Market Trends

Technological advancements are profoundly influencing the global drug screening market by improving test speed, accuracy, and the range of detected substances. Innovations in analytical techniques are crucial, especially as attempts to compromise test integrity rise. The 2024 Quest Diagnostics Drug Testing Index reported tampered drug tests in the general U. S. workforce increased over six-fold in 2023 from the prior year, underscoring the demand for robust screening methods. This drives the development of advanced portable devices and laboratory platforms.

Key Market Players

• Quest Diagnostics Inc.
• Heska Corporation
• Thermo Fisher Scientific, Inc.
• Alfa Scientific Designs, Inc.
• OraSure Technologies, Inc.
• F. Hoffmann-La Roche Ltd
• MPD Inc.
• Shimadzu Corporation
• Lifeloc Technologies, Inc.
• Dragerwerk AG & Co. KGaA
• Premier Biotech, Inc.
• Omega Laboratories, Inc.

Report Scope:

In this report, the Global Drug Screening Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Drug Screening Market, By Product & Services:

• Drug Screening Product
• Analytical Instruments
• Rapid Testing Devices
• Oral Fluid Testing Devices
• Consumables
• Drug Screening Service

Drug Screening Market, By Sample Type:

• Urine Samples
• Breath Samples
• Oral Fluid Samples
• Hair Samples
• Other Samples

Drug Screening Market, By End User:

• Drug Testing Laboratories
• Workplaces
• Criminal Justice and Law Enforcement Agencies
• Hospitals
• Drug Treatment Centers
• Individual Users
• Pain Management Centers
• Schools and Colleges

Drug Screening Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Drug Screening Market.

Available Customizations:

Global Drug Screening Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Drug Screening Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product & Services (Drug Screening Product, Analytical Instruments, Rapid Testing Devices, Oral Fluid Testing Devices, Consumables, Drug Screening Service)
  • 5.2.2. By Sample Type (Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other Samples)
  • 5.2.3. By End User (Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Drug Screening Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product & Services
  • 6.2.2. By Sample Type
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Drug Screening Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product & Services
      • 6.3.1.2.2. By Sample Type
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Drug Screening Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product & Services
      • 6.3.2.2.2. By Sample Type
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Drug Screening Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product & Services
      • 6.3.3.2.2. By Sample Type
      • 6.3.3.2.3. By End User

7. Europe Drug Screening Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product & Services
  • 7.2.2. By Sample Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Drug Screening Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product & Services
      • 7.3.1.2.2. By Sample Type
      • 7.3.1.2.3. By End User
  • 7.3.2. France Drug Screening Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product & Services
      • 7.3.2.2.2. By Sample Type
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Drug Screening Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product & Services
      • 7.3.3.2.2. By Sample Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Drug Screening Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product & Services
      • 7.3.4.2.2. By Sample Type
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Drug Screening Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product & Services
      • 7.3.5.2.2. By Sample Type
      • 7.3.5.2.3. By End User

8. Asia Pacific Drug Screening Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product & Services
  • 8.2.2. By Sample Type
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Drug Screening Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product & Services
      • 8.3.1.2.2. By Sample Type
      • 8.3.1.2.3. By End User
  • 8.3.2. India Drug Screening Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product & Services
      • 8.3.2.2.2. By Sample Type
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Drug Screening Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product & Services
      • 8.3.3.2.2. By Sample Type
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Drug Screening Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product & Services
      • 8.3.4.2.2. By Sample Type
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Drug Screening Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product & Services
      • 8.3.5.2.2. By Sample Type
      • 8.3.5.2.3. By End User

9. Middle East & Africa Drug Screening Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product & Services
  • 9.2.2. By Sample Type
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Drug Screening Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product & Services
      • 9.3.1.2.2. By Sample Type
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Drug Screening Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product & Services
      • 9.3.2.2.2. By Sample Type
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Drug Screening Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product & Services
      • 9.3.3.2.2. By Sample Type
      • 9.3.3.2.3. By End User

10. South America Drug Screening Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product & Services
  • 10.2.2. By Sample Type
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Drug Screening Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product & Services
      • 10.3.1.2.2. By Sample Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Drug Screening Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product & Services
      • 10.3.2.2.2. By Sample Type
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Drug Screening Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product & Services
      • 10.3.3.2.2. By Sample Type
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Drug Screening Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Quest Diagnostics Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Heska Corporation
• 15.3. Thermo Fisher Scientific, Inc.
• 15.4. Alfa Scientific Designs, Inc.
• 15.5. OraSure Technologies, Inc.
• 15.6. F. Hoffmann-La Roche Ltd
• 15.7. MPD Inc.
• 15.8. Shimadzu Corporation
• 15.9. Lifeloc Technologies, Inc.
• 15.10. Dragerwerk AG & Co. KGaA
• 15.11. Premier Biotech, Inc.
• 15.12. Omega Laboratories, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer